Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer
Go back to Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer| (NASDAQ: EWTX) | Delayed: 39.44 +0.13 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.31 | 52 Week High | $ | |||
| Open | $39.49 | 52 Week Low | $ | |||
| Day High | $40.44 | P/E | N/A | |||
| Day Low | $39.16 | EPS | $ | |||
| Volume | 164,015 | |||||



